Company news
TheraCryf PLC news in 2026
TheraCryf PLC's news releases, calls and decks from 2026, newest first.
Result of Annual General Meeting
October 22, 2026
Ox-1 Preclinical Data Package Complete
October 19, 2026
Holding(s) in Company
October 13, 2026
Change of Nominated Adviser
October 9, 2026
Australian partner to progress Ox-1 Phase 1 trial
October 2, 2026
Posting of Annual Report and Notice of AGM
September 30, 2026
Final Results for the year ended 31 March 2026
September 28, 2026
Notice of Results and Investor Presentation
September 14, 2026
Proposed Placing & Subscription to raise £1.05m
August 20, 2026
Positive Ox-1 tox data in addiction programme
May 14, 2026
Investor Webinar
April 21, 2026
Successful GMP Manufacture Advances Ox-1 to Clinic
April 20, 2026
New Manufacturing Process Patent for Ox-1
April 16, 2026
Non-Binding Proposal to Acquire TheraCryf’s Assets
April 14, 2026
Ox-1 Programme Advances to Final Toxicology Study
March 23, 2026
Ox-1 Addiction Programme Update
January 26, 2026
Key Ox-1 milestone & notice of investor webinar
January 5, 2026
Calls in 2026
Decks in 2026
- Shareholder Meeting (September 2026)
Shareholder meeting · 14 slides · Sep 7, 2026